Syndax Pharmaceuticals, Inc. SNDX
$12.90
-5.49%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-04 | View → |
| 8-K | 8-K | 2026-08-04 | View → |
| 8-K | 8-K | 2026-07-14 | View → |
| 4 | 4 | 2026-07-09 | View → |
| 4 | 4 | 2026-06-12 | View → |
| 8-K | 8-K | 2026-06-10 | View → |
| 8-K | 8-K | 2026-06-10 | View → |
| 8-K | 8-K | 2026-06-04 | View → |
| 4 | 4 | 2026-06-02 | View → |
| 4 | 4 | 2026-06-02 | View → |
| DEF 14A | DEF 14A | 2026-04-30 | View → |
| 10-Q | 10-Q | 2026-04-30 | View → |
| 8-K | 8-K | 2026-04-30 | View → |
| 10-K | 10-K | 2026-02-26 | View → |
| 8-K | 8-K | 2026-02-26 | View → |
| 4 | 4 | 2026-02-10 | View → |
| 4 | 4 | 2026-02-10 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 8-K | 8-K | 2026-01-12 | View → |
| 8-K | 8-K | 2025-12-19 | View → |
| 4 | 4 | 2025-12-01 | View → |
| 10-Q | 10-Q | 2025-11-03 | View → |
| 8-K | 8-K | 2025-11-03 | View → |
| 8-K | 8-K | 2025-10-24 | View → |
| 4 | 4 | 2025-09-08 | View → |
| 4 | 4 | 2025-08-18 | View → |
| 4 | 4 | 2025-08-07 | View → |
| 10-Q | 10-Q | 2025-08-04 | View → |
| 8-K | 8-K | 2025-08-04 | View → |
| 4 | 4 | 2025-07-18 | View → |
| 4 | 4 | 2025-07-18 | View → |
| 8-K | 8-K | 2025-06-26 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $12.90
- Market Cap
- $1.15 billion
- 52-Week Range
- $12.81 – $25.59
- Average Volume
- 2.08 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.